Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae273 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Christina G Hutten und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor MI 48109, USA. Hauptthemen laut MEDLINE: COVID-19, Obesity, Inflammation, Body Mass Index. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, University of Michigan Medicine, NHLBI NIH HHS.
Abstract (Originalsprache)
Context
Obesity is a risk factor for coronavirus disease 2019 (COVID-19)-related outcomes; however, the mechanism remains unclear.
Objective
The objective of this analysis was to determine whether inflammation mediates the association between obesity and COVID-19 outcomes.
Methods
The International Study of Inflammation in COVID-19 (ISIC): A Prospective Multi-Center Observational Study Examining the Role of Biomarkers of Inflammation in Predicting Covid-19 Related Outcomes in Hospitalized Patients, was conducted at 10 hospitals in the United States and Europe. Participants were adults hospitalized specifically for COVID-19 between February 1, 2020, through October 19, 2022. Inflammatory biomarkers, including soluble urokinase plasminogen activator receptor (suPAR), were measured at admission. Associations were examined between body mass index (BMI, kg/m2) and a composite of death, need for mechanical ventilation, and renal replacement therapy, stratified by pre- and post-Omicron variants. The contribution of inflammation to the relationship between obesity and outcomes was assessed.
Results
Among 4644 participants (mean age 59.3, 45.6% male, 21.8% BMI ≥ 35), those with BMI > 40 (n = 485) had 55% higher odds of the composite outcome (95% CI, 1.21-1.98) compared with nonobese individuals (BMI < 30, n = 2358) in multivariable analysis. In multiple mediation analysis, only suPAR remained a significant mediator between BMI and composite outcome. Associations were amplified for participants younger than 65 years and with pre-Omicron variants.
Conclusion
Obesity is associated with worse outcomes in COVID-19, notably in younger participants and in the pre-Omicron era. Inflammation, as measured by suPAR, is a significant mediator of the association between obesity and COVID-19 outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor MI 48109, USA.
- Department of Internal Medicine, University of Michigan, Ann Arbor MI 48109, USA.
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
- 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece.
- Clinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
- Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
ORCID-Profile: Christina G Hutten, Frank Tacke, Rodica Pop-Busui, Salim S Hayek
Förderung
- NIDDK NIH HHS
- University of Michigan Medicine
- NHLBI NIH HHS
- Michigan Diabetes Research Center
- Ortho Clinical Diagnostics
- Hellenic Institute for the Study of Sepsis
- Multidisciplinary Cardiovascular Training Grant
- Berlin Institute of Health
Zitieren
APA
Hutten, C. G., Padalia, K., Vasbinder, A., Huang, Y., Ismail, A., Pizzo, I., Machado Diaz, K., Catalan, T., Presswalla, F., Anderson, E., Erne, G., Bitterman, B., Blakely, P., Giamarellos-Bourboulis, E. J., Loosen, S. H., Tacke, F., Chalkias, A., Reiser, J., Eugen-Olsen, J., …, & Hayek, S. S. (2024). Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae273
Vancouver
Hutten CG, Padalia K, Vasbinder A, Huang Y, Ismail A, Pizzo I, et al. Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae273
BibTeX
@article{Hutten2024,
author = {Hutten, Christina G and Padalia, Kishan and Vasbinder, Alexi and Huang, Yiyuan and Ismail, Anis and Pizzo, Ian and Machado Diaz, Kristen and Catalan, Tonimarie and Presswalla, Feriel and Anderson, Elizabeth and Erne, Grace and Bitterman, Brayden and Blakely, Pennelope and Giamarellos-Bourboulis, Evangelos J and Loosen, Sven H and Tacke, Frank and Chalkias, Athanasios and Reiser, Jochen and Eugen-Olsen, Jesper and Banerjee, Mousumi and Pop-Busui, Rodica and Hayek, Salim S},
title = {Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae273}
}
EUVIMED